Pfizer Receives Positive CHMP Opinion for TALZENNA (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer
NEW YORK--(BUSINESS WIRE)--Apr 26, 2019--Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EM…
